About Infusion Pump Software
Infusion pumps are referred to as the medical devices, which are used for delivering nutrients, drugs, supplements and other fluids in the patient’s body in a measured quantity. These infusion pumps are embedded with the software, which help in maintains pumping mechanism, prescribed infusion rate and other crucial aspect of fluid delivery, for minimizing human errors. These software prevent the errors through managing dose quantity and alarming the medical professional to promote patient safety. Due to these advantages, the infusion software system is widely used in hospitals, nursing homes, and other ambulatory surgical center for better patient care.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 7.1% |
Mergers and acquisitions, expansions, investments, new service launches, and collaborations are among the companies' favored techniques for exploring the market. Players are expanding and acquiring businesses in new geographies in order to get a competitive edge through synergy. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Infusion Pump Software market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
BD (United States), ICU Medical, Inc. (United States), B. Braun (Germany), Baxter (United States), Terumo Medical (Japan), Fresenius Kabi (Germany), Moog (United States), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland) and Smiths Medical, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Ivenix, Inc. (United States), Eitan Medical (Israel) and Micrel Medical Devices.
Segmentation Overview
AMA Research has segmented the market of Global Infusion Pump Software market by Type (Clinical Workflow, Dose-error reduction software (DERS), Infusion rate calculating software and Others), Application (Pediatrics and Neonatology, Anti-Cancer Therapy, Pain Management and Other Therapy) and Region.
On the basis of geography, the market of Infusion Pump Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-user, the sub-segment i.e. Hospital will boost the Infusion Pump Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
New launch for smart infusion pumps for efficient delivery
Market Growth Drivers:
Rise in cases suffering from infusion-related errors and Increasing count of geriatric population requiring precise drug delivery
Challenges:
Lack of awareness in underdeveloped regions
Restraints:
Technological Glitch in the software
Opportunities:
Ongoing advancement in the infusion technology
Market Leaders and their expansionary development strategies
In April 2023, medaptus Announces Agreement with Fresenius Kabi to Offer Hospitals Financial Reimbursement Software for Infusion Services. The collaborating to help healthcare organizations in the U.S. manage reimbursement for infusion therapy and streamline the process of delivering and billing for infusion therapy.
In June 2023, B. Braun Medical Inc. (B. Braun) announced the launch of its next generation of infusion management software, DoseTrac® Enterprise Infusion Management Software. With this new software, organizations receive a mix of real-time views and retrospective reporting features to better understand their infusion pump fleet and associated data.
In June 2019, Ivenix, US based company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Ivenix Infusion System with the aim to make the infusions safer, and reduce the overall cost of ownership and In August 2020, the infusion therapy and pain management company, B. Braun Medical Inc. received received 510(k) approval from the US regulatory authority US Food and Drug Administration (US FDA) for its SpaceStation MRI to allow Space infusion pumps to continuously deliver medications to patients within the MRI suite
Key Target Audience
Manufacturers of medical devices and Governmental bodies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.